leadforensics

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner

PHARMA REPORT

rss_Pharma.jpg...see all
Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases

Product code: PHA0210

  • Publication date: 11/07/2017
  • Number of Pages: 188
  1. Report Details
  2. Table of Contents
  3. Companies Listed

Report Details

The pharma clinical trial services market is expected to grow at a CAGR of 9.5% in the first half of the forecast period. The market is expected to grow at a CAGR of 9.8% from 2016-2027. The pharma clinical trial services market is estimated at $39.56bn in 2016 dominated by the late-phase services, which held 56% of share.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 188-page report you will receive 145 charts – all unavailable elsewhere.

The 188-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Pharma Clinical Trial Services Market forecasts from 2017-2027

• This report breaks down the revenue forecast for pharma clinical trial services market by type of service:
• Early Phase Services
• Late Phase Services
• Other Services

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report breaks down the revenue forecast for pharma clinical trial services market by End-Users:
• Pharma
• Biotech Companies
• Other End-Users

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW
• This report breaks down the revenue forecast for pharma clinical trial services market by Therapeutic Area:
• Cancer
• Cardiovascular
• CNS
• Infectious Diseases
• Metabolic Diseases
• Other Diseases

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• North America: the US and Rest of North America
• Europe: France, Germany, the UK, Spain, Italy, Russia, Central and Eastern Europe, Rest of Europe
• Asia-Pacific: China, India, Japan, South Korea, Rest of APAC
• Rest of the World: Latin America, Middle East and Africa, Brazil

Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Each regional market is further divided by type of service, end-users and therapeutic area.

• Our study discusses factors that drive and restrain the pharma clinical trial services market. This report also provides a STEP analysis

• This report discusses the leading companies in pharma clinical trial services market:
• Quintiles IMS Holdings Inc.
• LabCorp (Covance Inc.)
• Pharmaceutical Product Development (PPD), LLC
• Parexel International Corporation
• ICON
• INC Research
• inVentiv Health
• PRA Health Sciences
• Chiltern International
• Charles River Laboratories

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma clinical trial services market. You find data, trends and predictions.

Buy our report today Pharma Clinical Trial Services Market and Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Table of Contents

1. Report Overview
1.1 Global Pharma Clinical Trial Services Market Overview
1.2 Why You Should Read This Report
1.3 Key Questions Answered by This Analytical Report
1.4 Structure of the Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Pharma Clinical Trial Services Market Introduction
2.1 Clinical Trials: A Historical Perspective
2.2 Design and Execution of Clinical Trials
2.3 Phases of Clinical Trials
2.3.1 Phase I Trials: First In-Human Studies
2.3.2 Phase II Trials: Proof-of- Concept
2.3.3 Phase III Trials: Drug Approval Applications
2.3.4 Post-Marketing Studies
2.3.5 Key Elements of Clinical Trials
2.4 Common Trial Designs
2.4.1 Improving Clinical Trial Models through Adaptive Trial Designs
2.5 Clinical Trial Outsourcing
2.5.1 Challenges Exist in Conducting Clinical Trials
2.5.2 Benefits of Outsourcing

3. Pharma Clinical Trial Services: World Market by Services 2016-2027
3.1 The Impact of Economy on the Clinical Trial Services Market 2017-2027
3.2 Pharma Clinical Trial Services Market by Services 2017-2027
3.2.1 Early Phase Clinical Trial Services Market Forecasts 2017-2027
3.2.2 Late Phase Clinical Trial Services Market Forecasts 2017-2027
3.2.3 Other Clinical Trial Services Market Forecasts 2017-2027

4. Pharma Clinical Trial Services: World Market by End-Users 2016-2027
4.1 The Evolution of the Clinical Research Organizations (CROs)
4.2 Pharma Clinical Trial Services Market by End-Users 2017-2027
4.2.1 Clinical Trial Services Market by Pharma End-Users Forecasts 2017-2027
4.2.2 Clinical Trial Services Market by Biotech Companies End-Users Forecasts 2017-2027
4.2.3 Clinical Trial Services Market by Other End-Users Forecasts 2017-2027

5. Pharma Clinical Trial Services: World Market by Therapeutic Areas 2017-2027
5.1 Rise of Clinical Trial Services in Key Therapeutic Areas
5.1.1 Cancer Clinical Trial Services Market Forecasts 2017-2027
5.1.2 Cardiovascular Diseases Clinical Trial Services Market Forecasts 2017-2027
5.1.3 CNS Diseases Clinical Trial Services Market Forecasts 2017-2027
5.1.4 Infectious Diseases Clinical Trial Services Market Forecasts 2017-2027
5.1.5 Metabolic Diseases Clinical Trial Services Market Forecasts 2017-2027
5.1.6 Other Diseases Clinical Trial Services Market Forecasts 2017-2027

6. Regional Pharma Clinical Trial Services Market Forecasts 2017-2027
6.1 North American Pharma Clinical Trial Services Market Forecasts 2017-2027
6.1.1 U.S. Pharma Clinical Trial Services Market Forecasts 2017-2027
6.1.2 Rest of North America Pharma Clinical Trial Services Market Forecasts 2017-2027
6.2 North American Pharma Clinical Trial Services Market Forecasts by Service 2017-2027
6.3 North American Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027
6.4 North American Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027
6.5 Europe Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.1 France Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.2 Germany Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.3 U.K. Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.4 Spain Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.5 Italy Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.6 Russia Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.7 Central and Eastern Europe Pharma Clinical Trial Services Market Forecasts 2017-2027
6.5.8 Rest of Europe Pharma Clinical Trial Services Market Forecasts 2017-2027
6.6 European Pharma Clinical Trial Services Market Forecasts by Service 2017-2027
6.7 European Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027
6.8 European Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027
6.9 Asia-Pacific Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.1 China Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.2 India Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.3 Japan Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.4 South Korea Pharma Clinical Trial Services Market Forecasts 2017-2027
6.9.5 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market Forecasts 2017-2027
6.10 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Service 2017-2027
6.11 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027
6.12 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027
6.13 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts 2017-2027
6.13.1 Latin America Pharma Clinical Trial Services Market Forecasts 2017-2027
6.13.2 Middle East and Africa Pharma Clinical Trial Services Market Forecasts 2017-2027
6.13.3 Brazil Pharma Clinical Trial Services Market Forecasts 2017-2027
6.14 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by Service 2017-2027
6.15 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by Therapeutic Area 2017-2027
6.16 Rest of the World (RoW) Pharma Clinical Trial Services Market Forecasts by End-Users 2017-2027

7. Drivers & Restraints
7.1 Drivers and Restraints 2017-2027
7.2 Drivers
7.2.1 Increased research and development by biopharmaceutical companies leading to better utilization of clinical trial services
7.2.2 Contract research organizations present in the emerging markets to gain major foothold in the forecast period
7.2.3 Growth of biopharma R&D expenditures will lead to increase in the clinical trial market
7.2.4 Emerging markets especially China becoming a much sought-after clinical trial destination
7.2.5 Increased Strategic Alliances among Large BioPharma Companies and CROs benefitting the market
7.3 Restraints
7.3.1 Regulatory Constraints such as longer approval time for clinical trials
7.3.2 Poor Physician and Nurse Engagement Leading to Low Patient Recruitment Rates

8. Leading Companies in the Pharma Clinical Trial Services Market
8.1 Quintiles IMS Holdings Inc.
8.1.1 Quintiles IMS Holdings Inc. Business Overview
8.1.2 Quintiles IMS Holdings Inc. Financial Overview
8.1.3 Quintiles IMS Holdings Inc. Corporate Strategy
8.2 LabCorp (Covance Inc.)
8.2.1 LabCorp Business Overview
8.2.2 LabCorp Financial Overview
8.2.3 LabCorp (Covance Inc.) Corporate Strategy
8.3 Pharmaceutical Product Development (PPD), LLC
8.3.1 Pharmaceutical Product Development (PPD) Business Overview
8.3.2 Pharmaceutical Product Development (PPD) Financial Overview
8.3.3 Pharmaceutical Product Development (PPD) Corporate Strategy
8.4 Parexel International Corporation
8.4.1 Parexel International Corporation Business Overview
8.4.2 Parexel International Corporation Financial Overview
8.4.3 Parexel International Corporation Corporate Strategy
8.5 ICON
8.5.1 ICON Business Overview
8.5.2 ICON Financial Overview
8.5.3 ICON Corporate Strategy
8.6 INC Research
8.6.1 INC Research Business Overview
8.6.2 INC Research Financial Overview
8.6.3 INC Research Corporate Strategy
8.7 inVentiv Health
8.7.1 inVentiv Health Business Overview
8.7.2 inVentiv Health Financial Overview
8.7.3 inVentiv Health Corporate Strategy
8.8 PRA Health Sciences
8.8.1 PRA Health Sciences Business Overview
8.8.2 PRA Health Sciences Financial Overview
8.8.3 PRA Health Sciences Corporate Strategy
8.9 Chiltern International
8.9.1 Chiltern International Business Overview
8.9.2 Chiltern International Financial Overview
8.9.3 Chiltern International Corporate Strategy
8.10 Charles River Laboratories
8.10.1 Charles River Laboratories Business Overview
8.10.2 Charles River Laboratories Financial Overview
8.10.3 Charles River Laboratories Corporate Strategy

9. STEP Analysis of the Pharma Clinical Trial Services Market 2017-2027
9.1 STEP Analysis of the Pharma Clinical Trial Services Market
9.2 Social Factors Affecting Clinical Trials
9.2.1 Ethical Considerations in Conducting Clinical Trials
9.2.2 Patient Recruitment: Major Challenge in Developed Markets
9.3 Technological Development for Improved Trials
9.3.1 Electronic Data Capture
9.3.2 eClinical Trial Tools
9.3.3 Use of Electronic Health Records for Faster Patient Recruitment
9.3.4 Cloud Computing used as a Tool for Multicentre Trials
9.4 Economic Considerations for Clinical Trial Outsourcing
9.4.1 Pharma is adjusting its R&D strategies
9.4.2 CROs tend to be attractive for Private Investigators
9.5 Political and Regulatory Considerations for Clinical Trial Outsourcing
9.5.1 Drug Safety and Clinical Trials Post-Approval
9.5.2 Cutting Red Tape and Other Regulatory Developments

10. Conclusions
10.1 Current Leading Pharma Clinical Trial Services Market Segments
10.1.1 Leading Contract Research Organizations
10.1.2 Leading Regional Markets
10.1.3 Emerging Pharma Clinical Trial Services Markets

Appendices
Glossary
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form

List of Figures
Figure 2.1 Brief History of Clinical Trials
Figure 3.1 Breakdown of Pharma Clinical Spending by Phase
Figure 3.2 Global Pharma Clinical Trial Services Market by Services: (% Share), 2016
Figure 3.3 Pharma Clinical Trial Services Market by Services: Revenue ($bn), 2016-2027
Figure 3.4 Early Phase Services Market Forecasts: AGR (%), 2017-2027
Figure 3.5 Global Early Phase Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027
Figure 3.6 Global Early Phase Clinical Trial Services Market Share by Region: (% Share), 2016-2027
Figure 3.7 Late Phase Clinical Trial Services Market Forecasts: AGR (%), 2017-2027
Figure 3.8 Global Late Phase Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027
Figure 3.9 Global Late Phase Clinical Trial Services by Region: (% Share), 2016-2027
Figure 3.10 Other Pharma Clinical Trial Services Submarket Forecasts: AGR (%), 2017-2027
Figure 3.11 Global Other Pharma Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027
Figure 3.12 Global Other Pharma Clinical Trial Services by Region: (% Share), 2016-2027
Figure 4.1 Pharma Clinical Trial Services Submarkets by End-Users: Revenue ($bn), 2016-2027
Figure 4.2 Clinical Trial Services Pharma Submarket: AGR (%), 2017-2027
Figure 4.3 Global Clinical Trial Services Pharma Submarket by Region: Revenue ($bn), 2016-2027
Figure 4.4 Global Clinical Trial Services Pharma Submarket by Region: (% Share), 2016-2027
Figure 4.5 Clinical Trial Services Biotech Companies Submarket: AGR (%), 2017-2027
Figure 4.6 Global Clinical Trial Services Biotech Companies Submarket by Region: Revenue ($bn), 2016-2027
Figure 4.7 Global Clinical Trial Services Biotech Companies Submarket by Region: (% Share), 2016-2027
Figure 4.8 Clinical Trial Services Other End-Users Submarket: AGR (%), 2017-2027
Figure 4.9 Global Clinical Trial Services Other End-Users Submarket by Region: Revenue ($bn), 2016-2027
Figure 4.10 Global Clinical Trial Services Other End-Users Submarket by Region: (% Share), 2016-2027
Figure 5.1 Global Pharma Clinical Trial Services Market by Therapeutic Area: (% Share), 2016
Figure 5.2 Pharma Clinical Trial Services Submarkets by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 5.3 Cancer Clinical Trial Services Submarket: AGR (%), 2017-2027
Figure 5.4 Global Cancer Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.5 Global Cancer Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.6 Cardiovascular Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027
Figure 5.7 Global Cardiovascular Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.8 Global Cardiovascular Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.9 CNS Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027
Figure 5.10 Global CNS Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.11 Global CNS Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.12 Infectious Diseases Clinical Trial Services Submarkets: AGR (%), 2017-2027
Figure 5.13 Global Infectious Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.14 Global Infectious Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.15 Metabolic Diseases Clinical Trial Services Submarkets: AGR (%), 2017-2027
Figure 5.16 Global Metabolic Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.17 Global Metabolic Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 5.18 Other Diseases Clinical Trial Services Submarket: AGR (%), 2017-2027
Figure 5.19 Global Other Diseases Clinical Trial Services Submarket by Region: Revenue ($bn), 2016-2027
Figure 5.20 Global Other Diseases Clinical Trial Services Submarket by Region: (% Share), 2016-2027
Figure 6.1 Regional Pharma Clinical Trial Services Markets: Revenue ($bn), 2017-2027
Figure 6.2 North American Pharma Clinical Trial Services by Country: (% Share), 2016
Figure 6.3 U.S. Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.4 Rest of North America Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.5 North American Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027
Figure 6.6 North American Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 6.7 North American Pharma Clinical Trial Services Market by End-Users: Revenue ($bn), 2016-2027
Figure 6.8 European Pharma Clinical Trial Services by Country: (% Share), 2016
Figure 6.9 France Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.10 Germany Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.11 U.K. Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.12 Spain Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.13 Italy Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.14 Russia Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.15 Central and Eastern Europe (CEE) Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.16 Rest of Europe Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.17 European Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027
Figure 6.18 European Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 6.19 European Pharma Clinical Trial Services Market by End-users: Revenue ($bn), 2016-2027
Figure 6.20 Asia-Pacific Pharma Clinical Trial Services Market Share by Country: (% Share), 2016
Figure 6.21 China Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.22 India Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.23 Japan Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.24 South Korea Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.25 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.26 Asia-Pacific Pharma Clinical Trial Services Market Revenue by Service: Revenue ($bn), 2016-2027
Figure 6.27 Asia-Pacific Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 6.28 Asia-Pacific Pharma Clinical Trial Services Market by End-Users: Revenue ($bn), 2016-2027
Figure 6.29 Rest of the World (RoW) Pharma Clinical Trial Services Market by Country (% Share), 2016
Figure 6.30 Latin America Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.31 Middle East and Africa Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.32 Brazil Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 6.33 RoW Pharma Clinical Trial Services Market by Service: Revenue ($bn), 2016-2027
Figure 6.34 RoW Pharma Clinical Trial Services Market by Therapeutic Area: Revenue ($bn), 2016-2027
Figure 6.35 RoW Pharma Clinical Trial Services Market Revenue by End-Users: Revenue ($bn), 2016-2027
Figure 7.1 Market: Drivers and Restraints, 2017-2027
Figure 8.1 Quintiles IMS Holdings Inc. 2016 Annual Revenue by Business Segment: (% Share)
Figure 8.2 LabCorp (Covance Inc.) 2016 Annual Revenue by Business Segments: (% Share)
Figure 8.3 LabCorp Annual Revenue 2012-2016 ($bn)
Figure 8.4 Pharmaceutical Product Development (PPD) 2010 Annual Revenue by Business Segment (% Share)
Figure 8.5 Parexel International Corporation 2016 Annual Revenue by Business Segment (% Share)
Figure 8.6 Parexel International Corporation Annual Revenue 2012- 2016 ($mn)
Figure 8.7 ICON Annual Revenue 2012- 2016 ($bn)
Figure 8.8 INC Research 2016 Annual Revenue by Business Segment: (% Share)
Figure 8.9 INC Research Annual Revenue 2012-2016 ($bn)
Figure 8.10 PRA Health Sciences 2016 Annual Revenue by Business Segment: (% Share)
Figure 8.11 PRA Health Sciences Annual Revenue 2012-2016 ($bn)
Figure 8.12 Charles River Laboratories 2016 Annual Revenue by Business Segment: (% Share)
Figure 8.13 Charles River Laboratories Annual Revenue 2012-2016 ($bn)
Figure 10.1 Global Pharma Clinical Trial Services Market: Revenue ($bn), 2016-2027
Figure 10.2 Pharma Clinical Trial Services Market by Region: Revenue ($bn), 2016-2027

List of Tables
Table 2.1 Founding Members of the ICH
Table 2.2 Types of Adaptive Trial Design
Table 3.1 Breakdown of Pharma Clinical Spending by Phase, 2014
Table 3.2 Breakdown of Pharma Clinical Trial Services by Services
Table 3.3 Table 3.3 Pharma Clinical Trial Services Market by Services: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 3.4 Table 3.4 Early Phase Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 3.5 Table 3.5 Late Phase Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 3.6 Other Pharma Clinical Trial Services Markets by Region: Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.1 Pharma Clinical Trial Services Submarket by End-Users: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 4.2 Clinical Trial Services Pharma Submarket by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 4.3 Clinical Trial Services Biotech Companies Submarket by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 4.4 Clinical Trial Services Other End-Users Submarket by Region: Forecasts ($bn, AGR%, CAGR%), 2016-2027
Table 5.1 Pharma Clinical Trial Services Submarkets by Therapeutic Area: Forecast ($bn, AGR %, CAGR%), 2016-2027
Table 5.2 Cancer Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.3 Cardiovascular Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.4 CNS Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.5 Infectious Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.6 Metabolic Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 5.7 Other Diseases Clinical Trial Services Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027
Table 6.1 Regional Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.2 U.S. Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.3 Rest of North America Pharma Clinical Trial Services Market: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.4 North American Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.5 North American Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.6 North American Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.7 France Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.8 Germany Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.9 U.K. Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.10 Spain Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.11 Italy Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.12 Russia Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.13 Central and Eastern Europe (CEE) Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.14 Rest of Europe Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.15 European Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.16 European Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.17 European Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.18 China Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.19 India Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.20 Japan Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.21 South Korea Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.22 Rest of Asia-Pacific (APAC) Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.23 Asia-Pacific Pharma Clinical Trial Services Market by Service: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.24 Asia-Pacific Pharma Clinical Trial Services Market Forecasts by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.25 Asia-Pacific Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.26 Latin America Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.27 Middle East and Africa Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.28 Brazil Pharma Clinical Trial Services Market: Forecasts ($bn, AGR% CAGR%), 2016-2027
Table 6.29 RoW Pharma Clinical Trial Services Market Forecasts by Service: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.30 RoW Pharma Clinical Trial Services Market by Therapeutic Area: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 6.31 RoW Pharma Clinical Trial Services Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027
Table 9.1 STEP Analysis of Pharma Clinical Trial Services Market 2016-2027

Companies Listed

3C Alliance
Actavis
Adamas Pharmaceuticals
Adheris (an InVentiv Health company)
Agilent Technologies
Agility Clinical
AKESOgen
Akos
Allscripts
Amgen
Aptiv Solutions (now part of ICON plc)
Aptuit
ASAN Medical Center
Assent Consulting
Astellas Pharma
Avista Capital Partners
Baxter International
Bayer
BeijingWits Medical Consulting (part of ICON)
Berry Consultants
BioBay
BioClinica
BioDuro (part of PPD)
BioDuro Biologics
Biogen Idec
Biomedical Systems
BioTrak
Bioxydyn
BML
Boehringer Ingelheim
Bridgepoint Development Capital
Bristol-Myers Squibb
Caprion
Catalent
Catalina Health (part of InVentiv Health)
Celerion
Charles River Laboratories
ClinForce
Clinical Trial Support
Clinigene International
Clinipace Worldwide
ClinStar
CMIC Holdings
CMIC (Beijing) Co
CNS Healthcare
CNS Vital Signs
Cogtest (part of The Cognition Group)
Corex Pharmaceutical
CRI Lifetree (part of PRA Health Sciences)
Cromos Pharma
CROMSOURCE
Cross Country Healthcare Inc
Czura Thornton
Dako (part of Agilent Technologies)
Duke Clinical Research Institute
EF Education First
Eisai
Ekam Imaging
Eli Lilly
EPS Corporation (now EPS Holdings, Inc.)
EPS Holdings, Inc.
Firecrest Clinical (part of ICON)
Forest Pharmaceuticals
Frontage Laboratories
GCP ClinPlus
GE Healthcare
Genstar Capital
Global CNS Research
Global Research Services (GRS)
Główny Urząd Statystyczny (Polish Central Statistical Office)
GSK
Harlan Laboratories (part of Huntingdon Life Sciences)
Hellman & Friedman
Hisun Pharmaceuticals
Huntingdon Life Sciences
i3 Research (part of inVentiv Health)
ICON
ImageIQ
ImmuneHealth
INC Research
Infociencia (part of RPS)
Inspire
Institute for Medical Research Management and Biometrics (IMEREM, part of RPS)
Integrium
inVentiv Health
J&J
Janssen Pharmaceuticals (a subsidiary of J&J)
Japan Pharmaceutical Manufacturers Association (JPMA)
Jasper Clinical Research and Development Inc.
Java Clinical
JCL Bioassay Corporation (part of CMIC Holdings)
Julphar
Kendle (part of INC Research)
Kester Capital
Kforce
Kforce Clinical Research (KCR, part of inVentiv Health)
Kinship Technologies (part of PRA Health Sciences)
KKR
Korea National Enterprise for Clinical Trials (KoNECT)
Kun Tuo (part of Quintiles)
Laboratory Corporation of America (LabCorp)
Les Entreprises du Médicament (LEEM)
LSK Global
MAB Discovery
Malaysian Biotechnology Corporation
Massachusetts General Hospital
Maximax Pharmaceutical Research
MDS Pharma Services (part of INC Research)
MedAvante
Medaxial
Medelis
Medicines and Healthcare products Regulatory Agency (MHRA) [UK]
Medidata Solutions
MediMedia Pharma Solutions (now part of ICON plc)
Medipal Holdings
Medivation
MEK Consulting (part of INC Research)
Merck & Co.
Merck BioVentures
Merck KGaA
Metabolon
MetricStream
Mitsubishi Gas Chemical Company, Inc.
Molecular NeuroImaging
MorphoSys
MPI Research
MRM Proteomics
Myriad Genetics
Mytrus
Nautic Partners
NeuroImage
NextGen Sciences
Nexus Oncology, an Ockham Company (formerly Nexus Oncology)
Novartis
Novotech
Ockham
OCT
Omnicare
Oncobiologics
Ontario Teachers' Pension Plan
Oxford Cancer Biomarkers
Oxford Gene Technology (OGT)
Oxford Outcomes (part of ICON)
Pacific Biomarkers
Paragon Biomedical (part of Clinipace Worldwide)
Paramax International (part of RPS)
Parexel International
PatientsLikeMe
Perceptive Informatics (part of Parexel)
PFC Pharma Focus (part of Clinipace Worldwide)
Pfizer
PharmaNet Development Group (part of inVentiv Health)
Pharmaron
PPD
PRA International
Prana Biotechnology
PriceSpective (part of ICON)
Prodia Clinical Laboratory
Proteome Sciences
ProTrials Research
PSR Orphan Experts
Psychmed (part of The Cognition Group)
QED Clinical Services
Quintiles
Quotient Clinical
RCT Logic
Regulus Pharmaceutical Consulting (part of Clinipace Worldwide)
ReSearch Pharmaceutical Services (RPS, part of PRA International)
Roche
Rules Based Medicine (now Myriad RBM, part of Myriad Genetics)
Samsung
SAS
ShangPharma
Shire
Syngene International
Sugi Medical Co (part of CMIC)
Taijitu Biologics
Targos Molecular Pathology
Tessella
The Carlyle Group
The Clinical Trial Company
The Cognition Group
Theorem Clinical Research
Theradex Systems
Therapharm Recherches (part of RPS)
Thomas H. Lee Partners
Tigermed Consulting
Timaq Medical Imaging (part of ICON)
Trident Clinical Research (part of INC Research)
UCB
University of Manchester
Veeda Clinical Research
Veeva Systems
Vigiun (part of Chiltern International)
VirtualScopics
Warburg Pincus
West Coast Clinical Trials (WCCT)
Worldwide Clinical Research
WuXi AppTec
WuXi PharmaTech
Yungjin Pharmaceutical
Zhejiang Jiang Yuan Tang Biotechnology Co., Ltd

Organizations Mentioned in Report
Administration of Science, Technology and Training (ASST) [Vietnam]
Agência Nacional de Vigilância Sanitária (ANVISA) [Brazil]
Agenzia Italiana del Farmaco (AIFA) [Italy]
Associação Brasileira de CROs (Abracro)
Association for the Accreditation of Human Research Protection Programs (AAHRPP)
Association of Clinical Trial Organisations (ACTO) [Russia]
Center for Biologics Evaluation and Research (CBER) [US]
CenterWatch
Central Drugs Standard Control Organization (CDSCO) [India]
Center for Drug Evaluation (CDE)
China Food and Drug Administration (CFDA)
Chinese Ministry of Commerce
Council for International Organizations of Medical Sciences (CIOMS)
Department of Health [UK]
Department of Health and Human Services [US]
Drug Controller General of India (DCGI)
European Commission
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency (EMA)
European Parliament
Food and Drug Administration (US FDA)
Hospital Italiano de Buenos Aires
Innovative Medicines Initiative (IMI)
International Cancer Genome Consortium
International Conference of Harmonisation (ICH)
Korea Drug Development Fund (KDDF)
Korea Food and Drug Administration (KFDA)
L'Agence Nationale de Sécurité du Medicament (L’ANSM) [France]
Ministry of Health, Labor and Welfare (MHLW, Japan)
Ministry of Public Health [Russia]
National Cancer Institute (NCI) [US]
National Institute for Health and Care Excellence (NICE) [UK]
National Institutes of Health (NIH) [US]
National Taiwan University Hospital (NTUH)
NHS Research Scotland (NRS)
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]
Seoul National University Hospital Clinical Trial Center
Shanghai Clinical Research Center
State Food and Drug Administration (SFDA) [China] (now CFDA)
Therapeutic Goods Administration (TGA) [Australia]
World Health Organization (WHO)
World Heart Foundation

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.

close